PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
174 hedge funds and large institutions have $304M invested in PDL BioPharma, Inc. in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 30
Holders
174
Holding in Top 10
–
Calls
$342K
Puts
$306K
Top Buyers
| 1 | +$32.5M | |
| 2 | +$7.48M | |
| 3 | +$5.55M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.18M |
| 5 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$2.71M |
Top Sellers
| 1 | -$4.42M | |
| 2 | -$2.88M | |
| 3 | -$2.56M | |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$2.28M |
| 5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$2.17M |